World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: KCT
Last refreshed on: 27 April 2013
Main ID:  KCT0000315
Date of registration: 09/01/2012
Primary sponsor: Korea Institute Planing and Evaluation for Technology of Food, Agriculture, Forestry and Fisheries
Public title: Weight-control Effect of Rice-based Diet
Scientific title: Weight-control Effect of Rice-based Diet
Date of first enrolment: 2012-01-13
Target sample size: 800
Recruitment status: Not yet recruiting
URL:  http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=1720
Study type:  Interventional Study
Study design:  Primary Purpose : Supportive Care, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT  
Countries of recruitment
Korea, Republic of
Contacts
Name: Jae  Kang
Address: 
Telephone:
Email:
Affiliation:  Inje University Seoul Paik Hospital
Name: Yang  Hur
Address: 
Telephone:
Email:
Affiliation:  Inje University Seoul Paik Hospital
Key inclusion & exclusion criteria
Inclusion criteria: ? any 3 of 5 constitute diagnosis of metabolic syndrome
1. Elevated waist circumference : =90 cm in men
=85 cm in women
2. Elevated triglycerides : =150 mg/dL (1.7 mmol/L)
or On drug treatment for elevated triglycerides
3. Reduced HDL-C : <40 mg/dL (1.03 mmol/L) in men
<50 mg/dL (1.3 mmol/L) in women
or On drug treatment for reduced HDL-C‡
4. Elevated blood pressure: =130 mm Hg systolic blood pressure or
=85 mm Hg diastolic blood pressure or
On antihypertensive drug treatment in a patient
with a history of hypertension
5. Elevated fasting glucose : =100 mg/dL
or On drug treatment for elevated glucose
? Patients who agreed to write about food diary and physical activity Questionnaire
? Patients who agreed to participate volutary in this clinical trial

Exclusion criteria: ? The patients with physical measurements are difficult due to anatomical change, such as surgical resection of part of the body
? The Patients with thyroid fuction disease (TSH is under 0.1 uU/ml, or over 10 uU/ml)
? The Patients with severe cerebrovascular disease(infarct, hemorrage), cardiac disease(angina, myocardiac infarct, heart failure, arrhythmias that require treatment) within recent 6 months. (If that patient's clinical status is stable, they can participate in the clinical trial according to investgator)
? The Patients with severe liver or kidney function abnormality
- plasma ALT or AST level is more than 3 times the upper limit of normal
- plsma creatinine level is more than 1.5 times the upper limit of normal
? The Patients with mental illness such as depression, Schizophrenia, alcoholism, drug addiction etc.
? Pregnant and lactating women, and women of childbearing age who do not agree with choose an appropriate contraceptive method or are planning to pregnant
? The patient who take the medicine that can affect the state of weight, glucose and lipid level (uptake inhibitors, antidepressant, appetite suppressant, antiobesity-related health functional food / supplements, antipsychotics, contraceptives, steroid, and hormon)within recent 3 months
? The patients who had surgical procedure for reducing weight (bariatric surgery such as gastric bypass and gastric banding)
? The patients who lose weignt over 10 percent within 3 months
? The patients who took part in other clinical trial within 3 months
? The patients who cannot excersise due to severe musculoskeletal disorders
? The patients who stopped smoking within recent 6 months or chage frequently smoking habit
? The patients who have low motivation for attending or will not following the observances of this clinical trial, depend on opinion of representative clinical trials


Age minimum: 20(Year)
Age maximum: 60(Year)
Gender: Both
Health Condition(s) or Problem(s) studied
Endocrine, nutritional and metabolic disease
Intervention(s)
Behavioral : Both groups will be provided low-calory, low-fat and low-sodium diet education and nutrition education materials at 0 week and 12week.
Additionally, rice-based diet group will be educated to eat rice-based diet(rice which mix white-rice and brown-rice at a ratio of 80:20) three times a day.
Primary Outcome(s)
blood pressure
fasting glucose
HDL-cholesterol
triglyceride
waist circumference
weight
Secondary Outcome(s)
body mass index
calory of each diet
fat maas, free fat mass
highly sensitive C-reactive protein(hsCRP)
hip circumference
insulin
LDL-cholesterol
Nutrients of each diet
total-cholesterol
Secondary ID(s)
Source(s) of Monetary Support
Secondary Sponsor(s)
Inju University Seoul Paik Hospitial Institute for Clinical Nutrition
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history